ThomasINychaySGSchwartzRALambertWCJannigerCK.The red face: Cutaneous lymphomas. Clin Dermatol1993;11:319–28.
2.
ReynoldsWRFeldmanMIBricoutPBPotdarGG.Mycosis fungoides in the maxillary sinus and oral cavity: Report of two cases. J Oral Surg1981;39:373–7.
3.
FerlitoAGianfrancoR.Laryngeal involvement by mycosis fungoides. Ann Otol Rhinol Laryngol1986;95:275–7.
4.
CheridjianZ.Mycosis fungoides du pharynx et rhinopharynx lateral chez un sclerodermique. Schweiz Med Wochenschr1947;77:366–9.
5.
RedleafMIMoranWJGruberB.Mycosis fungoides involving the cervical esophagus. Arch Otolaryngol Head Neck Surg1993;119:690–3.
6.
CraneRMHeydtS.Gingival involvement in mycosis fungoides: Report of case. J Oral Surg1979;37:585–7.
7.
ZackheimHSLeboCFWassersteinPMycosis fungoides of the mastoid, middle ear, and CNS: Literature Review of mycosis fungoides of the CNS. Arch Dermatol1983; 119: 311–8.
8.
DerkayCHirschBEAbellE.Pathology quiz case 2. Arch Otolaryngol Head Neck Surg1987;113:332–6.
9.
WhitbeckEGSpiersASDHussainM.Mycosis fungoides: Subcutaneous and visceral tumors, orbital involvement, and ophthalmoplegia. J Clin Oncol1983;1:270–6.
10.
BurgGDummerRKerlH.Classification of cutaneous lymphomas. Dermatol Clin1994;12:213–7.
11.
StrahanRWCalcaterraTC.Otolaryngologic aspects of mycosis fungoides: A case report. Laryngoscope1971; 81: 1912–6.
12.
RappaportHThomasLB.Mycosis fungoides: The pathology of extracutaneous involvement. Cancer1974;34:1198–229.
13.
EpsteinEHLevinDLCroftJDLutznerMA.Mycosis fungoides: Survival; prognostic features, response to therapy, and autopsy findings. Medicine1972;15:61–72.
14.
LongJCMihmMC.Mycosis fungoides with extracutaneous dissemination: A distinct clinicopathologic entity. Cancer1974;32:1385–95.
15.
KuhnJJWenigBMClarkDA.Mycosis fungoides of the larynx: Report of two cases and Review of the literature. Arch Otolaryngol Head Neck Surg1992;118:853–8.
16.
TillmanHH.Malignant lymphoma involving the oral cavity and surrounding structures. Oral Surg1965;19:60–72.
17.
CalhounNRJohnsonCC.Oral manifestations of mycosis fungoides. Oral Surg1966;22:261–4.
18.
RestEBHornTD.Immunophenotypic analysis of benign and malignant cutaneous lymphoid infiltrates. Clin Dermatol1991;9:261–72.
19.
TerhuneMHCooperKD.Gene rearrangements and T-cell lymphomas. Arch Dermatol1993;129:1484–90.
20.
JorgGKerlHThiersBHBrockerEBBurgG.Therapeutic approaches in cutaneous lymphoma. Dermatol Clin1994; 12: 433–41.
21.
HollowayKBFlowersFPRamos-CaroFA.Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol1992;27:367–78.
22.
KuzelTMRoenigkHHRosenST.Mycosis fungoides and the Sezary syndrome: A Review of pathogenesis, diagnosis, and therapy. J Clin Oncol1991;9:1298–313.
23.
SausvilleEAEddyJLMakuchRWHistopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Ann Intern Med1988;109:372–82.
24.
WillemzeRBeljaardsRC.Spectrum of primary cutaneous CD 30 (Ki-1)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol1993;28:973–80.
25.
GriemMLTokarsRPPetrasVCombined therapy for patients with mycosis fungoides. Cancer Treatment Reports1979;63:655–756.
26.
HallahanDEGriemMLGriemSFCombined modality therapy for tumor stage mycosis fungoides: Results of a 10-year follow-up. J Clin Oncol1988;6:1177–83.
27.
BravermanIMYagerNBChenMCombined total body electron beam irradiation and chemotherapy for mycosis fungoides. J Am Acad Dermatol1987;16:45–60.
28.
WinklerCFSausvilleEAIhdeDCCombined modality treatment of cutaneous T-cell lymphoma: Results of a 6-year follow-up. J Clin Oncol1986;4:1094–100.
29.
SlaterDN.Diagnostic difficulties in 'non-mycotic' cutaneous lymphoproliferative disorders. Histopathology1992;21:203–13.
30.
BunnPALambertSI.Report of the Committee on Staging and Classification of cutaneous T-cell lymphomas. Cancer Treatment Reports1979;63:725–8.
